nodes	percent_of_prediction	percent_of_DWPC	metapath
Prazosin—SLC22A2—Cladribine—multiple sclerosis	0.124	0.198	CbGbCtD
Prazosin—SLC22A1—Cladribine—multiple sclerosis	0.108	0.172	CbGbCtD
Prazosin—ABCG2—Cladribine—multiple sclerosis	0.0914	0.146	CbGbCtD
Prazosin—ABCG2—Mitoxantrone—multiple sclerosis	0.0666	0.107	CbGbCtD
Prazosin—ABCG2—Dexamethasone—multiple sclerosis	0.0346	0.0552	CbGbCtD
Prazosin—ABCB1—Methylprednisolone—multiple sclerosis	0.0329	0.0527	CbGbCtD
Prazosin—CYP1A1—Dexamethasone—multiple sclerosis	0.0319	0.051	CbGbCtD
Prazosin—HTR1D—trigeminal nucleus—multiple sclerosis	0.0307	0.226	CbGeAlD
Prazosin—ABCG2—Methotrexate—multiple sclerosis	0.0278	0.0444	CbGbCtD
Prazosin—ABCB1—Mitoxantrone—multiple sclerosis	0.024	0.0384	CbGbCtD
Prazosin—ABCB1—Betamethasone—multiple sclerosis	0.0214	0.0342	CbGbCtD
Prazosin—ABCB1—Prednisolone—multiple sclerosis	0.0211	0.0338	CbGbCtD
Prazosin—HTR1D—meninx—multiple sclerosis	0.0204	0.15	CbGeAlD
Prazosin—ABCB1—Prednisone—multiple sclerosis	0.02	0.0319	CbGbCtD
Prazosin—ABCB1—Dexamethasone—multiple sclerosis	0.0125	0.0199	CbGbCtD
Prazosin—ABCB1—Methotrexate—multiple sclerosis	0.01	0.016	CbGbCtD
Prazosin—MT3—nerve—multiple sclerosis	0.00997	0.0734	CbGeAlD
Prazosin—HTR1D—trigeminal nerve—multiple sclerosis	0.00805	0.0593	CbGeAlD
Prazosin—MT3—brainstem—multiple sclerosis	0.00428	0.0315	CbGeAlD
Prazosin—MT3—medulla oblongata—multiple sclerosis	0.00298	0.022	CbGeAlD
Prazosin—MT3—spinal cord—multiple sclerosis	0.00266	0.0196	CbGeAlD
Prazosin—MT3—nervous system—multiple sclerosis	0.00224	0.0165	CbGeAlD
Prazosin—KCNH7—nervous system—multiple sclerosis	0.00224	0.0165	CbGeAlD
Prazosin—ADRA2A—peripheral nervous system—multiple sclerosis	0.0022	0.0162	CbGeAlD
Prazosin—MT3—central nervous system—multiple sclerosis	0.00216	0.0159	CbGeAlD
Prazosin—KCNH7—central nervous system—multiple sclerosis	0.00216	0.0159	CbGeAlD
Prazosin—MT3—cerebellum—multiple sclerosis	0.00211	0.0155	CbGeAlD
Prazosin—KCNH7—cerebellum—multiple sclerosis	0.00211	0.0155	CbGeAlD
Prazosin—MT3—brain—multiple sclerosis	0.00171	0.0126	CbGeAlD
Prazosin—KCNH7—brain—multiple sclerosis	0.00171	0.0126	CbGeAlD
Prazosin—KCNH6—nervous system—multiple sclerosis	0.0016	0.0118	CbGeAlD
Prazosin—KCNH6—central nervous system—multiple sclerosis	0.00154	0.0113	CbGeAlD
Prazosin—HTR1D—brainstem—multiple sclerosis	0.00126	0.0093	CbGeAlD
Prazosin—KCNH6—brain—multiple sclerosis	0.00122	0.00899	CbGeAlD
Prazosin—HTR1A—brainstem—multiple sclerosis	0.00105	0.00775	CbGeAlD
Prazosin—ADRA1A—brainstem—multiple sclerosis	0.00097	0.00714	CbGeAlD
Prazosin—ADRA1B—nervous system—multiple sclerosis	0.000905	0.00666	CbGeAlD
Prazosin—ADRA1D—nervous system—multiple sclerosis	0.000885	0.00652	CbGeAlD
Prazosin—ADRA1B—central nervous system—multiple sclerosis	0.000871	0.00641	CbGeAlD
Prazosin—ORM1—spinal cord—multiple sclerosis	0.000865	0.00637	CbGeAlD
Prazosin—ADRA1D—central nervous system—multiple sclerosis	0.000852	0.00627	CbGeAlD
Prazosin—HTR1D—midbrain—multiple sclerosis	0.000805	0.00592	CbGeAlD
Prazosin—ORM1—nervous system—multiple sclerosis	0.000729	0.00537	CbGeAlD
Prazosin—ORM1—central nervous system—multiple sclerosis	0.000702	0.00517	CbGeAlD
Prazosin—ADRA1B—brain—multiple sclerosis	0.000691	0.00509	CbGeAlD
Prazosin—ADRA1D—brain—multiple sclerosis	0.000676	0.00498	CbGeAlD
Prazosin—HTR1A—midbrain—multiple sclerosis	0.000671	0.00494	CbGeAlD
Prazosin—SLC22A1—nervous system—multiple sclerosis	0.000668	0.00492	CbGeAlD
Prazosin—HTR1D—nervous system—multiple sclerosis	0.000661	0.00487	CbGeAlD
Prazosin—HTR1A—spinal cord—multiple sclerosis	0.000654	0.00482	CbGeAlD
Prazosin—KCNH2—medulla oblongata—multiple sclerosis	0.000653	0.00481	CbGeAlD
Prazosin—SLC22A1—central nervous system—multiple sclerosis	0.000643	0.00473	CbGeAlD
Prazosin—SLC22A3—nervous system—multiple sclerosis	0.000638	0.0047	CbGeAlD
Prazosin—HTR1D—central nervous system—multiple sclerosis	0.000637	0.00469	CbGeAlD
Prazosin—SLC22A3—central nervous system—multiple sclerosis	0.000614	0.00452	CbGeAlD
Prazosin—KCNH2—midbrain—multiple sclerosis	0.000597	0.0044	CbGeAlD
Prazosin—KCNH2—spinal cord—multiple sclerosis	0.000583	0.00429	CbGeAlD
Prazosin—ABCG2—medulla oblongata—multiple sclerosis	0.000581	0.00428	CbGeAlD
Prazosin—HTR1A—nervous system—multiple sclerosis	0.000551	0.00406	CbGeAlD
Prazosin—ABCG2—midbrain—multiple sclerosis	0.000531	0.00391	CbGeAlD
Prazosin—HTR1A—central nervous system—multiple sclerosis	0.000531	0.00391	CbGeAlD
Prazosin—HTR1A—cerebellum—multiple sclerosis	0.000519	0.00382	CbGeAlD
Prazosin—ABCG2—spinal cord—multiple sclerosis	0.000518	0.00382	CbGeAlD
Prazosin—ADRA2A—medulla oblongata—multiple sclerosis	0.000514	0.00379	CbGeAlD
Prazosin—SLC22A1—brain—multiple sclerosis	0.00051	0.00376	CbGeAlD
Prazosin—ADRA1A—nervous system—multiple sclerosis	0.000508	0.00374	CbGeAlD
Prazosin—HTR1D—brain—multiple sclerosis	0.000506	0.00372	CbGeAlD
Prazosin—KCNH2—nervous system—multiple sclerosis	0.000491	0.00361	CbGeAlD
Prazosin—ADRA1A—central nervous system—multiple sclerosis	0.000489	0.0036	CbGeAlD
Prazosin—SLC22A3—brain—multiple sclerosis	0.000488	0.00359	CbGeAlD
Prazosin—ADRA1A—cerebellum—multiple sclerosis	0.000478	0.00352	CbGeAlD
Prazosin—KCNH2—central nervous system—multiple sclerosis	0.000473	0.00348	CbGeAlD
Prazosin—ADRA2A—midbrain—multiple sclerosis	0.00047	0.00346	CbGeAlD
Prazosin—KCNH2—cerebellum—multiple sclerosis	0.000462	0.0034	CbGeAlD
Prazosin—ADRA2A—spinal cord—multiple sclerosis	0.000459	0.00338	CbGeAlD
Prazosin—Hallucination—Methylprednisolone—multiple sclerosis	0.000435	0.00341	CcSEcCtD
Prazosin—Arthralgia—Mitoxantrone—multiple sclerosis	0.000431	0.00338	CcSEcCtD
Prazosin—Diarrhoea—Cladribine—multiple sclerosis	0.00043	0.00337	CcSEcCtD
Prazosin—Discomfort—Mitoxantrone—multiple sclerosis	0.000425	0.00334	CcSEcCtD
Prazosin—Pancreatitis—Prednisone—multiple sclerosis	0.000424	0.00333	CcSEcCtD
Prazosin—Sweating increased—Prednisone—multiple sclerosis	0.000422	0.0033	CcSEcCtD
Prazosin—HTR1A—brain—multiple sclerosis	0.000421	0.0031	CbGeAlD
Prazosin—Feeling abnormal—Azathioprine—multiple sclerosis	0.000421	0.0033	CcSEcCtD
Prazosin—Dizziness—Cladribine—multiple sclerosis	0.000415	0.00326	CcSEcCtD
Prazosin—CYP1A1—nervous system—multiple sclerosis	0.000415	0.00305	CbGeAlD
Prazosin—Oedema—Mitoxantrone—multiple sclerosis	0.000413	0.00324	CcSEcCtD
Prazosin—ABCG2—cerebellum—multiple sclerosis	0.000411	0.00303	CbGeAlD
Prazosin—Shock—Mitoxantrone—multiple sclerosis	0.000406	0.00318	CcSEcCtD
Prazosin—Bradycardia—Dexamethasone—multiple sclerosis	0.000405	0.00317	CcSEcCtD
Prazosin—Bradycardia—Betamethasone—multiple sclerosis	0.000405	0.00317	CcSEcCtD
Prazosin—Body temperature increased—Azathioprine—multiple sclerosis	0.000404	0.00316	CcSEcCtD
Prazosin—Tachycardia—Mitoxantrone—multiple sclerosis	0.000403	0.00316	CcSEcCtD
Prazosin—Vomiting—Cladribine—multiple sclerosis	0.000399	0.00313	CcSEcCtD
Prazosin—CYP1A1—central nervous system—multiple sclerosis	0.000399	0.00294	CbGeAlD
Prazosin—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000399	0.00313	CcSEcCtD
Prazosin—Erectile dysfunction—Prednisone—multiple sclerosis	0.000399	0.00312	CcSEcCtD
Prazosin—ABCB1—retina—multiple sclerosis	0.000396	0.00292	CbGeAlD
Prazosin—Rash—Cladribine—multiple sclerosis	0.000396	0.0031	CcSEcCtD
Prazosin—Hallucination—Dexamethasone—multiple sclerosis	0.000396	0.0031	CcSEcCtD
Prazosin—Hallucination—Betamethasone—multiple sclerosis	0.000396	0.0031	CcSEcCtD
Prazosin—Dermatitis—Cladribine—multiple sclerosis	0.000396	0.0031	CcSEcCtD
Prazosin—Headache—Cladribine—multiple sclerosis	0.000393	0.00308	CcSEcCtD
Prazosin—Vision blurred—Prednisolone—multiple sclerosis	0.000391	0.00307	CcSEcCtD
Prazosin—ADRA1A—brain—multiple sclerosis	0.000388	0.00286	CbGeAlD
Prazosin—ADRA2A—nervous system—multiple sclerosis	0.000386	0.00285	CbGeAlD
Prazosin—Ill-defined disorder—Prednisolone—multiple sclerosis	0.000385	0.00302	CcSEcCtD
Prazosin—Hypersensitivity—Azathioprine—multiple sclerosis	0.000376	0.00295	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000376	0.00295	CcSEcCtD
Prazosin—KCNH2—brain—multiple sclerosis	0.000375	0.00276	CbGeAlD
Prazosin—Malaise—Prednisolone—multiple sclerosis	0.000374	0.00293	CcSEcCtD
Prazosin—Nausea—Cladribine—multiple sclerosis	0.000373	0.00292	CcSEcCtD
Prazosin—Vertigo—Prednisolone—multiple sclerosis	0.000373	0.00292	CcSEcCtD
Prazosin—Syncope—Prednisolone—multiple sclerosis	0.000372	0.00292	CcSEcCtD
Prazosin—ADRA2A—central nervous system—multiple sclerosis	0.000372	0.00274	CbGeAlD
Prazosin—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000371	0.00291	CcSEcCtD
Prazosin—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000368	0.00288	CcSEcCtD
Prazosin—Somnolence—Mitoxantrone—multiple sclerosis	0.000367	0.00288	CcSEcCtD
Prazosin—Loss of consciousness—Prednisolone—multiple sclerosis	0.000365	0.00286	CcSEcCtD
Prazosin—ADRA2A—cerebellum—multiple sclerosis	0.000364	0.00268	CbGeAlD
Prazosin—Fatigue—Mitoxantrone—multiple sclerosis	0.000356	0.00279	CcSEcCtD
Prazosin—Pancreatitis—Methotrexate—multiple sclerosis	0.000355	0.00278	CcSEcCtD
Prazosin—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000354	0.00278	CcSEcCtD
Prazosin—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000353	0.00277	CcSEcCtD
Prazosin—Pain—Mitoxantrone—multiple sclerosis	0.000353	0.00277	CcSEcCtD
Prazosin—Constipation—Mitoxantrone—multiple sclerosis	0.000353	0.00277	CcSEcCtD
Prazosin—Bradycardia—Prednisone—multiple sclerosis	0.000353	0.00276	CcSEcCtD
Prazosin—Alopecia—Betamethasone—multiple sclerosis	0.000351	0.00276	CcSEcCtD
Prazosin—Alopecia—Dexamethasone—multiple sclerosis	0.000351	0.00276	CcSEcCtD
Prazosin—Diarrhoea—Azathioprine—multiple sclerosis	0.000349	0.00274	CcSEcCtD
Prazosin—Discomfort—Prednisolone—multiple sclerosis	0.000349	0.00274	CcSEcCtD
Prazosin—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000347	0.00272	CcSEcCtD
Prazosin—Hallucination—Prednisone—multiple sclerosis	0.000345	0.0027	CcSEcCtD
Prazosin—Malaise—Triamcinolone—multiple sclerosis	0.000344	0.0027	CcSEcCtD
Prazosin—Malaise—Methylprednisolone—multiple sclerosis	0.000343	0.00269	CcSEcCtD
Prazosin—Vertigo—Triamcinolone—multiple sclerosis	0.000343	0.00269	CcSEcCtD
Prazosin—Syncope—Triamcinolone—multiple sclerosis	0.000342	0.00268	CcSEcCtD
Prazosin—Vertigo—Methylprednisolone—multiple sclerosis	0.000342	0.00268	CcSEcCtD
Prazosin—Syncope—Methylprednisolone—multiple sclerosis	0.000341	0.00268	CcSEcCtD
Prazosin—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00034	0.00267	CcSEcCtD
Prazosin—Oedema—Prednisolone—multiple sclerosis	0.000339	0.00265	CcSEcCtD
Prazosin—Dizziness—Azathioprine—multiple sclerosis	0.000338	0.00265	CcSEcCtD
Prazosin—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000335	0.00263	CcSEcCtD
Prazosin—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000335	0.00262	CcSEcCtD
Prazosin—ABCG2—brain—multiple sclerosis	0.000334	0.00246	CbGeAlD
Prazosin—Shock—Prednisolone—multiple sclerosis	0.000333	0.00261	CcSEcCtD
Prazosin—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000333	0.00261	CcSEcCtD
Prazosin—Tachycardia—Prednisolone—multiple sclerosis	0.000331	0.00259	CcSEcCtD
Prazosin—Urticaria—Mitoxantrone—multiple sclerosis	0.000328	0.00257	CcSEcCtD
Prazosin—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000327	0.00257	CcSEcCtD
Prazosin—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000326	0.00256	CcSEcCtD
Prazosin—Vomiting—Azathioprine—multiple sclerosis	0.000325	0.00255	CcSEcCtD
Prazosin—Arthralgia—Methylprednisolone—multiple sclerosis	0.000324	0.00254	CcSEcCtD
Prazosin—Drowsiness—Methotrexate—multiple sclerosis	0.000322	0.00253	CcSEcCtD
Prazosin—Rash—Azathioprine—multiple sclerosis	0.000322	0.00252	CcSEcCtD
Prazosin—Dermatitis—Azathioprine—multiple sclerosis	0.000322	0.00252	CcSEcCtD
Prazosin—Flushing—Prednisone—multiple sclerosis	0.000321	0.00252	CcSEcCtD
Prazosin—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000321	0.00252	CcSEcCtD
Prazosin—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000321	0.00252	CcSEcCtD
Prazosin—Discomfort—Triamcinolone—multiple sclerosis	0.000321	0.00252	CcSEcCtD
Prazosin—Discomfort—Methylprednisolone—multiple sclerosis	0.00032	0.00251	CcSEcCtD
Prazosin—Headache—Azathioprine—multiple sclerosis	0.00032	0.00251	CcSEcCtD
Prazosin—Dry mouth—Triamcinolone—multiple sclerosis	0.000318	0.00249	CcSEcCtD
Prazosin—CYP1A1—brain—multiple sclerosis	0.000317	0.00233	CbGeAlD
Prazosin—Malaise—Betamethasone—multiple sclerosis	0.000312	0.00245	CcSEcCtD
Prazosin—Malaise—Dexamethasone—multiple sclerosis	0.000312	0.00245	CcSEcCtD
Prazosin—Oedema—Triamcinolone—multiple sclerosis	0.000311	0.00244	CcSEcCtD
Prazosin—Vertigo—Dexamethasone—multiple sclerosis	0.000311	0.00244	CcSEcCtD
Prazosin—Vertigo—Betamethasone—multiple sclerosis	0.000311	0.00244	CcSEcCtD
Prazosin—Syncope—Dexamethasone—multiple sclerosis	0.000311	0.00243	CcSEcCtD
Prazosin—Syncope—Betamethasone—multiple sclerosis	0.000311	0.00243	CcSEcCtD
Prazosin—Shock—Triamcinolone—multiple sclerosis	0.000306	0.0024	CcSEcCtD
Prazosin—Insomnia—Prednisolone—multiple sclerosis	0.000306	0.0024	CcSEcCtD
Prazosin—Alopecia—Prednisone—multiple sclerosis	0.000306	0.0024	CcSEcCtD
Prazosin—Shock—Methylprednisolone—multiple sclerosis	0.000306	0.0024	CcSEcCtD
Prazosin—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000304	0.00239	CcSEcCtD
Prazosin—Loss of consciousness—Betamethasone—multiple sclerosis	0.000304	0.00239	CcSEcCtD
Prazosin—Epistaxis—Methotrexate—multiple sclerosis	0.000304	0.00238	CcSEcCtD
Prazosin—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000304	0.00238	CcSEcCtD
Prazosin—Paraesthesia—Prednisolone—multiple sclerosis	0.000304	0.00238	CcSEcCtD
Prazosin—Tachycardia—Triamcinolone—multiple sclerosis	0.000304	0.00238	CcSEcCtD
Prazosin—Nausea—Azathioprine—multiple sclerosis	0.000303	0.00238	CcSEcCtD
Prazosin—Tachycardia—Methylprednisolone—multiple sclerosis	0.000303	0.00238	CcSEcCtD
Prazosin—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000301	0.00236	CcSEcCtD
Prazosin—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.0003	0.00235	CcSEcCtD
Prazosin—Asthenia—Mitoxantrone—multiple sclerosis	0.000296	0.00232	CcSEcCtD
Prazosin—ADRA2A—brain—multiple sclerosis	0.000295	0.00218	CbGeAlD
Prazosin—Discomfort—Dexamethasone—multiple sclerosis	0.000291	0.00228	CcSEcCtD
Prazosin—Discomfort—Betamethasone—multiple sclerosis	0.000291	0.00228	CcSEcCtD
Prazosin—Pain—Prednisolone—multiple sclerosis	0.00029	0.00227	CcSEcCtD
Prazosin—ABCB1—medulla oblongata—multiple sclerosis	0.000287	0.00211	CbGeAlD
Prazosin—Vision blurred—Prednisone—multiple sclerosis	0.000284	0.00223	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000284	0.00222	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000283	0.00222	CcSEcCtD
Prazosin—Oedema—Dexamethasone—multiple sclerosis	0.000283	0.00222	CcSEcCtD
Prazosin—Oedema—Betamethasone—multiple sclerosis	0.000283	0.00222	CcSEcCtD
Prazosin—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000282	0.00221	CcSEcCtD
Prazosin—Insomnia—Triamcinolone—multiple sclerosis	0.000282	0.00221	CcSEcCtD
Prazosin—Insomnia—Methylprednisolone—multiple sclerosis	0.000281	0.0022	CcSEcCtD
Prazosin—Ill-defined disorder—Prednisone—multiple sclerosis	0.00028	0.00219	CcSEcCtD
Prazosin—Paraesthesia—Triamcinolone—multiple sclerosis	0.00028	0.00219	CcSEcCtD
Prazosin—Feeling abnormal—Prednisolone—multiple sclerosis	0.000279	0.00219	CcSEcCtD
Prazosin—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000279	0.00219	CcSEcCtD
Prazosin—Shock—Dexamethasone—multiple sclerosis	0.000278	0.00218	CcSEcCtD
Prazosin—Shock—Betamethasone—multiple sclerosis	0.000278	0.00218	CcSEcCtD
Prazosin—Dyspnoea—Triamcinolone—multiple sclerosis	0.000278	0.00218	CcSEcCtD
Prazosin—Tachycardia—Dexamethasone—multiple sclerosis	0.000276	0.00216	CcSEcCtD
Prazosin—Tachycardia—Betamethasone—multiple sclerosis	0.000276	0.00216	CcSEcCtD
Prazosin—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000273	0.00214	CcSEcCtD
Prazosin—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000273	0.00214	CcSEcCtD
Prazosin—Malaise—Prednisone—multiple sclerosis	0.000272	0.00213	CcSEcCtD
Prazosin—Vertigo—Prednisone—multiple sclerosis	0.000271	0.00212	CcSEcCtD
Prazosin—Syncope—Prednisone—multiple sclerosis	0.00027	0.00212	CcSEcCtD
Prazosin—Tinnitus—Methotrexate—multiple sclerosis	0.00027	0.00212	CcSEcCtD
Prazosin—Urticaria—Prednisolone—multiple sclerosis	0.000269	0.00211	CcSEcCtD
Prazosin—Fatigue—Triamcinolone—multiple sclerosis	0.000269	0.0021	CcSEcCtD
Prazosin—Fatigue—Methylprednisolone—multiple sclerosis	0.000268	0.0021	CcSEcCtD
Prazosin—Pain—Triamcinolone—multiple sclerosis	0.000266	0.00209	CcSEcCtD
Prazosin—Loss of consciousness—Prednisone—multiple sclerosis	0.000265	0.00208	CcSEcCtD
Prazosin—Vomiting—Mitoxantrone—multiple sclerosis	0.000262	0.00206	CcSEcCtD
Prazosin—ABCB1—midbrain—multiple sclerosis	0.000262	0.00193	CbGeAlD
Prazosin—Rash—Mitoxantrone—multiple sclerosis	0.00026	0.00204	CcSEcCtD
Prazosin—Dermatitis—Mitoxantrone—multiple sclerosis	0.00026	0.00204	CcSEcCtD
Prazosin—Headache—Mitoxantrone—multiple sclerosis	0.000259	0.00203	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000257	0.00202	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000257	0.00202	CcSEcCtD
Prazosin—Arthralgia—Prednisone—multiple sclerosis	0.000257	0.00201	CcSEcCtD
Prazosin—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000257	0.00201	CcSEcCtD
Prazosin—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000256	0.00201	CcSEcCtD
Prazosin—Alopecia—Methotrexate—multiple sclerosis	0.000256	0.00201	CcSEcCtD
Prazosin—Insomnia—Betamethasone—multiple sclerosis	0.000256	0.002	CcSEcCtD
Prazosin—Insomnia—Dexamethasone—multiple sclerosis	0.000256	0.002	CcSEcCtD
Prazosin—ABCB1—spinal cord—multiple sclerosis	0.000256	0.00188	CbGeAlD
Prazosin—Paraesthesia—Dexamethasone—multiple sclerosis	0.000254	0.00199	CcSEcCtD
Prazosin—Paraesthesia—Betamethasone—multiple sclerosis	0.000254	0.00199	CcSEcCtD
Prazosin—Discomfort—Prednisone—multiple sclerosis	0.000254	0.00199	CcSEcCtD
Prazosin—Hypersensitivity—Prednisolone—multiple sclerosis	0.00025	0.00196	CcSEcCtD
Prazosin—Urticaria—Triamcinolone—multiple sclerosis	0.000247	0.00194	CcSEcCtD
Prazosin—Urticaria—Methylprednisolone—multiple sclerosis	0.000247	0.00194	CcSEcCtD
Prazosin—Body temperature increased—Triamcinolone—multiple sclerosis	0.000246	0.00193	CcSEcCtD
Prazosin—Oedema—Prednisone—multiple sclerosis	0.000246	0.00193	CcSEcCtD
Prazosin—Nausea—Mitoxantrone—multiple sclerosis	0.000245	0.00192	CcSEcCtD
Prazosin—Fatigue—Dexamethasone—multiple sclerosis	0.000244	0.00191	CcSEcCtD
Prazosin—Fatigue—Betamethasone—multiple sclerosis	0.000244	0.00191	CcSEcCtD
Prazosin—Shock—Prednisone—multiple sclerosis	0.000242	0.0019	CcSEcCtD
Prazosin—Pain—Betamethasone—multiple sclerosis	0.000242	0.00189	CcSEcCtD
Prazosin—Pain—Dexamethasone—multiple sclerosis	0.000242	0.00189	CcSEcCtD
Prazosin—Tachycardia—Prednisone—multiple sclerosis	0.00024	0.00188	CcSEcCtD
Prazosin—Hyperhidrosis—Prednisone—multiple sclerosis	0.000238	0.00186	CcSEcCtD
Prazosin—Vision blurred—Methotrexate—multiple sclerosis	0.000237	0.00186	CcSEcCtD
Prazosin—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000234	0.00183	CcSEcCtD
Prazosin—Feeling abnormal—Betamethasone—multiple sclerosis	0.000233	0.00183	CcSEcCtD
Prazosin—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000233	0.00183	CcSEcCtD
Prazosin—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000229	0.0018	CcSEcCtD
Prazosin—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000229	0.00179	CcSEcCtD
Prazosin—Malaise—Methotrexate—multiple sclerosis	0.000227	0.00178	CcSEcCtD
Prazosin—Vertigo—Methotrexate—multiple sclerosis	0.000226	0.00177	CcSEcCtD
Prazosin—Urticaria—Betamethasone—multiple sclerosis	0.000224	0.00176	CcSEcCtD
Prazosin—Urticaria—Dexamethasone—multiple sclerosis	0.000224	0.00176	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000224	0.00176	CcSEcCtD
Prazosin—Dizziness—Prednisolone—multiple sclerosis	0.000224	0.00176	CcSEcCtD
Prazosin—Asthenia—Triamcinolone—multiple sclerosis	0.000223	0.00175	CcSEcCtD
Prazosin—Body temperature increased—Betamethasone—multiple sclerosis	0.000223	0.00175	CcSEcCtD
Prazosin—Body temperature increased—Dexamethasone—multiple sclerosis	0.000223	0.00175	CcSEcCtD
Prazosin—Asthenia—Methylprednisolone—multiple sclerosis	0.000223	0.00175	CcSEcCtD
Prazosin—Insomnia—Prednisone—multiple sclerosis	0.000223	0.00174	CcSEcCtD
Prazosin—Paraesthesia—Prednisone—multiple sclerosis	0.000221	0.00173	CcSEcCtD
Prazosin—Pruritus—Triamcinolone—multiple sclerosis	0.00022	0.00173	CcSEcCtD
Prazosin—Pruritus—Methylprednisolone—multiple sclerosis	0.00022	0.00172	CcSEcCtD
Prazosin—ABCB1—nervous system—multiple sclerosis	0.000215	0.00159	CbGeAlD
Prazosin—Arthralgia—Methotrexate—multiple sclerosis	0.000215	0.00168	CcSEcCtD
Prazosin—Rash—Prednisolone—multiple sclerosis	0.000214	0.00167	CcSEcCtD
Prazosin—Dermatitis—Prednisolone—multiple sclerosis	0.000213	0.00167	CcSEcCtD
Prazosin—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000213	0.00167	CcSEcCtD
Prazosin—Fatigue—Prednisone—multiple sclerosis	0.000212	0.00166	CcSEcCtD
Prazosin—Headache—Prednisolone—multiple sclerosis	0.000212	0.00166	CcSEcCtD
Prazosin—Discomfort—Methotrexate—multiple sclerosis	0.000212	0.00166	CcSEcCtD
Prazosin—Constipation—Prednisone—multiple sclerosis	0.00021	0.00165	CcSEcCtD
Prazosin—ABCB1—central nervous system—multiple sclerosis	0.000207	0.00153	CbGeAlD
Prazosin—Dizziness—Triamcinolone—multiple sclerosis	0.000206	0.00161	CcSEcCtD
Prazosin—Dizziness—Methylprednisolone—multiple sclerosis	0.000205	0.00161	CcSEcCtD
Prazosin—Feeling abnormal—Prednisone—multiple sclerosis	0.000203	0.00159	CcSEcCtD
Prazosin—Asthenia—Betamethasone—multiple sclerosis	0.000203	0.00159	CcSEcCtD
Prazosin—Asthenia—Dexamethasone—multiple sclerosis	0.000203	0.00159	CcSEcCtD
Prazosin—ABCB1—cerebellum—multiple sclerosis	0.000203	0.00149	CbGeAlD
Prazosin—Nausea—Prednisolone—multiple sclerosis	0.000201	0.00158	CcSEcCtD
Prazosin—Pruritus—Betamethasone—multiple sclerosis	0.0002	0.00157	CcSEcCtD
Prazosin—Pruritus—Dexamethasone—multiple sclerosis	0.0002	0.00157	CcSEcCtD
Prazosin—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000199	0.00156	CcSEcCtD
Prazosin—Vomiting—Triamcinolone—multiple sclerosis	0.000198	0.00155	CcSEcCtD
Prazosin—Vomiting—Methylprednisolone—multiple sclerosis	0.000198	0.00155	CcSEcCtD
Prazosin—Rash—Triamcinolone—multiple sclerosis	0.000196	0.00154	CcSEcCtD
Prazosin—Dermatitis—Triamcinolone—multiple sclerosis	0.000196	0.00154	CcSEcCtD
Prazosin—Rash—Methylprednisolone—multiple sclerosis	0.000196	0.00154	CcSEcCtD
Prazosin—Dermatitis—Methylprednisolone—multiple sclerosis	0.000196	0.00153	CcSEcCtD
Prazosin—Urticaria—Prednisone—multiple sclerosis	0.000195	0.00153	CcSEcCtD
Prazosin—Headache—Triamcinolone—multiple sclerosis	0.000195	0.00153	CcSEcCtD
Prazosin—Headache—Methylprednisolone—multiple sclerosis	0.000195	0.00153	CcSEcCtD
Prazosin—Body temperature increased—Prednisone—multiple sclerosis	0.000195	0.00152	CcSEcCtD
Prazosin—Diarrhoea—Betamethasone—multiple sclerosis	0.000193	0.00152	CcSEcCtD
Prazosin—Diarrhoea—Dexamethasone—multiple sclerosis	0.000193	0.00152	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000187	0.00147	CcSEcCtD
Prazosin—Dizziness—Dexamethasone—multiple sclerosis	0.000187	0.00146	CcSEcCtD
Prazosin—Dizziness—Betamethasone—multiple sclerosis	0.000187	0.00146	CcSEcCtD
Prazosin—Insomnia—Methotrexate—multiple sclerosis	0.000186	0.00146	CcSEcCtD
Prazosin—Nausea—Triamcinolone—multiple sclerosis	0.000185	0.00145	CcSEcCtD
Prazosin—Paraesthesia—Methotrexate—multiple sclerosis	0.000185	0.00145	CcSEcCtD
Prazosin—Nausea—Methylprednisolone—multiple sclerosis	0.000185	0.00145	CcSEcCtD
Prazosin—Dyspnoea—Methotrexate—multiple sclerosis	0.000183	0.00144	CcSEcCtD
Prazosin—Somnolence—Methotrexate—multiple sclerosis	0.000183	0.00143	CcSEcCtD
Prazosin—Hypersensitivity—Prednisone—multiple sclerosis	0.000181	0.00142	CcSEcCtD
Prazosin—Vomiting—Dexamethasone—multiple sclerosis	0.00018	0.00141	CcSEcCtD
Prazosin—Vomiting—Betamethasone—multiple sclerosis	0.00018	0.00141	CcSEcCtD
Prazosin—Rash—Dexamethasone—multiple sclerosis	0.000178	0.0014	CcSEcCtD
Prazosin—Rash—Betamethasone—multiple sclerosis	0.000178	0.0014	CcSEcCtD
Prazosin—Dermatitis—Dexamethasone—multiple sclerosis	0.000178	0.0014	CcSEcCtD
Prazosin—Dermatitis—Betamethasone—multiple sclerosis	0.000178	0.0014	CcSEcCtD
Prazosin—Fatigue—Methotrexate—multiple sclerosis	0.000177	0.00139	CcSEcCtD
Prazosin—Headache—Dexamethasone—multiple sclerosis	0.000177	0.00139	CcSEcCtD
Prazosin—Headache—Betamethasone—multiple sclerosis	0.000177	0.00139	CcSEcCtD
Prazosin—Asthenia—Prednisone—multiple sclerosis	0.000177	0.00138	CcSEcCtD
Prazosin—Pain—Methotrexate—multiple sclerosis	0.000176	0.00138	CcSEcCtD
Prazosin—Pruritus—Prednisone—multiple sclerosis	0.000174	0.00136	CcSEcCtD
Prazosin—Feeling abnormal—Methotrexate—multiple sclerosis	0.000169	0.00133	CcSEcCtD
Prazosin—Diarrhoea—Prednisone—multiple sclerosis	0.000168	0.00132	CcSEcCtD
Prazosin—Nausea—Dexamethasone—multiple sclerosis	0.000168	0.00132	CcSEcCtD
Prazosin—Nausea—Betamethasone—multiple sclerosis	0.000168	0.00132	CcSEcCtD
Prazosin—ABCB1—brain—multiple sclerosis	0.000165	0.00121	CbGeAlD
Prazosin—Urticaria—Methotrexate—multiple sclerosis	0.000163	0.00128	CcSEcCtD
Prazosin—Dizziness—Prednisone—multiple sclerosis	0.000163	0.00128	CcSEcCtD
Prazosin—Body temperature increased—Methotrexate—multiple sclerosis	0.000163	0.00127	CcSEcCtD
Prazosin—Vomiting—Prednisone—multiple sclerosis	0.000156	0.00123	CcSEcCtD
Prazosin—Rash—Prednisone—multiple sclerosis	0.000155	0.00122	CcSEcCtD
Prazosin—Dermatitis—Prednisone—multiple sclerosis	0.000155	0.00122	CcSEcCtD
Prazosin—Headache—Prednisone—multiple sclerosis	0.000154	0.00121	CcSEcCtD
Prazosin—Hypersensitivity—Methotrexate—multiple sclerosis	0.000152	0.00119	CcSEcCtD
Prazosin—Asthenia—Methotrexate—multiple sclerosis	0.000148	0.00116	CcSEcCtD
Prazosin—Nausea—Prednisone—multiple sclerosis	0.000146	0.00115	CcSEcCtD
Prazosin—Pruritus—Methotrexate—multiple sclerosis	0.000146	0.00114	CcSEcCtD
Prazosin—Diarrhoea—Methotrexate—multiple sclerosis	0.000141	0.0011	CcSEcCtD
Prazosin—Dizziness—Methotrexate—multiple sclerosis	0.000136	0.00107	CcSEcCtD
Prazosin—Vomiting—Methotrexate—multiple sclerosis	0.000131	0.00103	CcSEcCtD
Prazosin—Rash—Methotrexate—multiple sclerosis	0.00013	0.00102	CcSEcCtD
Prazosin—Dermatitis—Methotrexate—multiple sclerosis	0.00013	0.00102	CcSEcCtD
Prazosin—Headache—Methotrexate—multiple sclerosis	0.000129	0.00101	CcSEcCtD
Prazosin—Nausea—Methotrexate—multiple sclerosis	0.000122	0.000958	CcSEcCtD
Prazosin—ADRA1B—Signaling by GPCR—CCR5—multiple sclerosis	1.99e-05	0.000179	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CCR2—multiple sclerosis	1.99e-05	0.000179	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CXCR3—multiple sclerosis	1.97e-05	0.000177	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—CCL5—multiple sclerosis	1.96e-05	0.000177	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—IL2RA—multiple sclerosis	1.96e-05	0.000177	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CD28—multiple sclerosis	1.95e-05	0.000176	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.95e-05	0.000175	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—CCR5—multiple sclerosis	1.95e-05	0.000175	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—TYK2—multiple sclerosis	1.95e-05	0.000175	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.95e-05	0.000175	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—PTGER4—multiple sclerosis	1.94e-05	0.000175	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—IL2RA—multiple sclerosis	1.92e-05	0.000173	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CCR2—multiple sclerosis	1.92e-05	0.000172	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—PGR—multiple sclerosis	1.91e-05	0.000172	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.91e-05	0.000172	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CXCR3—multiple sclerosis	1.88e-05	0.000169	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—POMC—multiple sclerosis	1.87e-05	0.000169	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CD86—multiple sclerosis	1.87e-05	0.000168	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—POMC—multiple sclerosis	1.86e-05	0.000168	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CD28—multiple sclerosis	1.86e-05	0.000167	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CCL5—multiple sclerosis	1.84e-05	0.000165	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—CCL2—multiple sclerosis	1.83e-05	0.000165	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CNR1—multiple sclerosis	1.83e-05	0.000165	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—POMC—multiple sclerosis	1.83e-05	0.000165	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CXCL10—multiple sclerosis	1.83e-05	0.000164	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CCR2—multiple sclerosis	1.83e-05	0.000164	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—CCL5—multiple sclerosis	1.82e-05	0.000164	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.82e-05	0.000163	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—CCR5—multiple sclerosis	1.81e-05	0.000163	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—POMC—multiple sclerosis	1.8e-05	0.000162	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CCL3—multiple sclerosis	1.79e-05	0.000161	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—IL2RA—multiple sclerosis	1.78e-05	0.00016	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—IL2—multiple sclerosis	1.78e-05	0.00016	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CNR1—multiple sclerosis	1.77e-05	0.000159	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—CCR5—multiple sclerosis	1.77e-05	0.000159	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.76e-05	0.000159	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—BCHE—multiple sclerosis	1.76e-05	0.000158	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—IL2RA—multiple sclerosis	1.74e-05	0.000157	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PTGER4—multiple sclerosis	1.73e-05	0.000155	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—POMC—multiple sclerosis	1.71e-05	0.000154	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—SPP1—multiple sclerosis	1.7e-05	0.000153	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—TGFB1—multiple sclerosis	1.7e-05	0.000153	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PGR—multiple sclerosis	1.7e-05	0.000153	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—POMC—multiple sclerosis	1.69e-05	0.000152	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CNR1—multiple sclerosis	1.68e-05	0.000152	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—ALB—multiple sclerosis	1.67e-05	0.00015	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—MAPK1—multiple sclerosis	1.67e-05	0.00015	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CXCR3—multiple sclerosis	1.67e-05	0.00015	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—TYK2—multiple sclerosis	1.67e-05	0.00015	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CCL3—multiple sclerosis	1.67e-05	0.00015	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—CCL2—multiple sclerosis	1.66e-05	0.000149	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CCR5—multiple sclerosis	1.66e-05	0.000149	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—IL2—multiple sclerosis	1.65e-05	0.000149	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CD28—multiple sclerosis	1.65e-05	0.000149	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CXCL10—multiple sclerosis	1.65e-05	0.000148	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—CCR5—multiple sclerosis	1.64e-05	0.000148	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—POMC—multiple sclerosis	1.63e-05	0.000147	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—IL2RA—multiple sclerosis	1.63e-05	0.000147	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CCR2—multiple sclerosis	1.62e-05	0.000146	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—IL2—multiple sclerosis	1.62e-05	0.000146	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—IL2RA—multiple sclerosis	1.62e-05	0.000146	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.61e-05	0.000145	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PTGER4—multiple sclerosis	1.6e-05	0.000144	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—CCL2—multiple sclerosis	1.6e-05	0.000144	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CD86—multiple sclerosis	1.6e-05	0.000144	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CXCL10—multiple sclerosis	1.59e-05	0.000143	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PGR—multiple sclerosis	1.58e-05	0.000142	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CCL5—multiple sclerosis	1.57e-05	0.000142	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—POMC—multiple sclerosis	1.56e-05	0.00014	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CXCR3—multiple sclerosis	1.55e-05	0.000139	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CD28—multiple sclerosis	1.53e-05	0.000138	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—IL2—multiple sclerosis	1.53e-05	0.000137	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—CCL2—multiple sclerosis	1.52e-05	0.000137	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—POMC—multiple sclerosis	1.52e-05	0.000137	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—BCHE—multiple sclerosis	1.52e-05	0.000137	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CXCL10—multiple sclerosis	1.52e-05	0.000136	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CCR2—multiple sclerosis	1.51e-05	0.000136	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—APOE—multiple sclerosis	1.51e-05	0.000136	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—TYK2—multiple sclerosis	1.5e-05	0.000135	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CNR1—multiple sclerosis	1.5e-05	0.000135	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—SPP1—multiple sclerosis	1.46e-05	0.000131	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—TYK2—multiple sclerosis	1.45e-05	0.000131	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CD86—multiple sclerosis	1.44e-05	0.00013	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CCL5—multiple sclerosis	1.42e-05	0.000128	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CCR5—multiple sclerosis	1.42e-05	0.000128	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—POMC—multiple sclerosis	1.41e-05	0.000127	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—IL2RA—multiple sclerosis	1.4e-05	0.000126	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CD86—multiple sclerosis	1.39e-05	0.000125	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CNR1—multiple sclerosis	1.39e-05	0.000125	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—IL2—multiple sclerosis	1.39e-05	0.000125	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—TYK2—multiple sclerosis	1.38e-05	0.000124	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—POMC—multiple sclerosis	1.38e-05	0.000124	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—IL2—multiple sclerosis	1.38e-05	0.000124	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CCL5—multiple sclerosis	1.37e-05	0.000123	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CD80—multiple sclerosis	1.36e-05	0.000123	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—CCL2—multiple sclerosis	1.35e-05	0.000122	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—APOE—multiple sclerosis	1.35e-05	0.000122	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CXCL10—multiple sclerosis	1.35e-05	0.000121	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—APOE—multiple sclerosis	1.34e-05	0.00012	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—IL2—multiple sclerosis	1.33e-05	0.00012	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CD86—multiple sclerosis	1.33e-05	0.000119	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—SPP1—multiple sclerosis	1.32e-05	0.000118	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CCL5—multiple sclerosis	1.31e-05	0.000117	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—POMC—multiple sclerosis	1.29e-05	0.000116	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—TGFB1—multiple sclerosis	1.29e-05	0.000116	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—APOE—multiple sclerosis	1.29e-05	0.000116	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—POMC—multiple sclerosis	1.28e-05	0.000116	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CCR5—multiple sclerosis	1.28e-05	0.000115	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—SPP1—multiple sclerosis	1.27e-05	0.000114	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—IL2—multiple sclerosis	1.27e-05	0.000114	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CCL2—multiple sclerosis	1.27e-05	0.000114	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—MAPK1—multiple sclerosis	1.27e-05	0.000114	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IL2RA—multiple sclerosis	1.26e-05	0.000113	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—CCL2—multiple sclerosis	1.26e-05	0.000113	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CXCL10—multiple sclerosis	1.25e-05	0.000113	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—IL2—multiple sclerosis	1.25e-05	0.000113	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—APOE—multiple sclerosis	1.25e-05	0.000112	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—MAPK1—multiple sclerosis	1.24e-05	0.000111	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CCR5—multiple sclerosis	1.24e-05	0.000111	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—TYK2—multiple sclerosis	1.23e-05	0.000111	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.22e-05	0.00011	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IL2RA—multiple sclerosis	1.22e-05	0.00011	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—BCHE—multiple sclerosis	1.21e-05	0.000109	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—SPP1—multiple sclerosis	1.21e-05	0.000109	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—IL2—multiple sclerosis	1.21e-05	0.000109	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	1.18e-05	0.000106	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CCR5—multiple sclerosis	1.18e-05	0.000106	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CD80—multiple sclerosis	1.17e-05	0.000105	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—APOE—multiple sclerosis	1.16e-05	0.000105	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—POMC—multiple sclerosis	1.16e-05	0.000104	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	1.16e-05	0.000104	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IL2RA—multiple sclerosis	1.16e-05	0.000104	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—IL2—multiple sclerosis	1.15e-05	0.000104	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—TYK2—multiple sclerosis	1.15e-05	0.000103	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—POMC—multiple sclerosis	1.15e-05	0.000103	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—TYK2—multiple sclerosis	1.14e-05	0.000103	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	1.13e-05	0.000101	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—APOE—multiple sclerosis	1.12e-05	0.000101	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—POMC—multiple sclerosis	1.11e-05	9.97e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	1.09e-05	9.85e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CCL2—multiple sclerosis	1.08e-05	9.75e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	1.08e-05	9.7e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	1.07e-05	9.66e-05	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—POMC—multiple sclerosis	1.07e-05	9.63e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—APOE—multiple sclerosis	1.07e-05	9.63e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—MAPK1—multiple sclerosis	1.06e-05	9.54e-05	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—ALB—multiple sclerosis	1.06e-05	9.52e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—APOE—multiple sclerosis	1.06e-05	9.5e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CD80—multiple sclerosis	1.05e-05	9.47e-05	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—ALB—multiple sclerosis	1.05e-05	9.42e-05	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	1.05e-05	9.41e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	1.04e-05	9.4e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	1.03e-05	9.26e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	1.02e-05	9.19e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CD80—multiple sclerosis	1.02e-05	9.14e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—POMC—multiple sclerosis	1e-05	9e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	9.98e-06	8.98e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—TYK2—multiple sclerosis	9.84e-06	8.85e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CCL2—multiple sclerosis	9.78e-06	8.8e-05	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—ALB—multiple sclerosis	9.76e-06	8.78e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	9.71e-06	8.73e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CD80—multiple sclerosis	9.67e-06	8.71e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—POMC—multiple sclerosis	9.65e-06	8.69e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—MAPK1—multiple sclerosis	9.57e-06	8.61e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	9.57e-06	8.61e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—IL2—multiple sclerosis	9.57e-06	8.61e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—IL6—multiple sclerosis	9.52e-06	8.57e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	9.5e-06	8.55e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	9.49e-06	8.54e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	9.44e-06	8.5e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	9.24e-06	8.31e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—POMC—multiple sclerosis	9.19e-06	8.27e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—APOE—multiple sclerosis	9.14e-06	8.23e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—POMC—multiple sclerosis	9.07e-06	8.16e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—MMP9—multiple sclerosis	9.05e-06	8.15e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CCL2—multiple sclerosis	8.99e-06	8.09e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—TYK2—multiple sclerosis	8.88e-06	7.99e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	8.83e-06	7.95e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—MAPK1—multiple sclerosis	8.8e-06	7.92e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	8.59e-06	7.73e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	8.58e-06	7.72e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—ALB—multiple sclerosis	8.27e-06	7.44e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—IL2—multiple sclerosis	8.19e-06	7.37e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—TYK2—multiple sclerosis	8.17e-06	7.35e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	8.16e-06	7.35e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—IL6—multiple sclerosis	8.15e-06	7.33e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—STAT3—multiple sclerosis	8.05e-06	7.24e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	7.99e-06	7.19e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	7.98e-06	7.18e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—POMC—multiple sclerosis	7.85e-06	7.07e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	7.82e-06	7.03e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—MMP9—multiple sclerosis	7.75e-06	6.97e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	7.59e-06	6.83e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—MYC—multiple sclerosis	7.48e-06	6.73e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—TGFB1—multiple sclerosis	7.46e-06	6.71e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	7.42e-06	6.68e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IL2—multiple sclerosis	7.39e-06	6.65e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—IL6—multiple sclerosis	7.36e-06	6.62e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—MAPK1—multiple sclerosis	7.32e-06	6.58e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—APOE—multiple sclerosis	7.3e-06	6.57e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	7.26e-06	6.54e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	7.25e-06	6.53e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—ALB—multiple sclerosis	7.16e-06	6.44e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IL2—multiple sclerosis	7.14e-06	6.42e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	7.1e-06	6.39e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—MMP9—multiple sclerosis	7e-06	6.3e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—STAT3—multiple sclerosis	6.89e-06	6.2e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IL2—multiple sclerosis	6.8e-06	6.11e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—IL6—multiple sclerosis	6.76e-06	6.08e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	6.75e-06	6.08e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	6.74e-06	6.07e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—MMP9—multiple sclerosis	6.43e-06	5.79e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—MYC—multiple sclerosis	6.4e-06	5.76e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—TGFB1—multiple sclerosis	6.39e-06	5.75e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—POMC—multiple sclerosis	6.27e-06	5.65e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—MAPK1—multiple sclerosis	6.26e-06	5.64e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—STAT3—multiple sclerosis	6.22e-06	5.6e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	6.04e-06	5.43e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	6.01e-06	5.4e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	6e-06	5.4e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—MYC—multiple sclerosis	5.78e-06	5.2e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—TGFB1—multiple sclerosis	5.77e-06	5.19e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—ALB—multiple sclerosis	5.72e-06	5.15e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—STAT3—multiple sclerosis	5.72e-06	5.15e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	5.71e-06	5.14e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—MAPK1—multiple sclerosis	5.65e-06	5.09e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—IL6—multiple sclerosis	5.62e-06	5.06e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	5.61e-06	5.05e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	5.58e-06	5.02e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—MYC—multiple sclerosis	5.58e-06	5.02e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	5.57e-06	5.01e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	5.46e-06	4.91e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—MYC—multiple sclerosis	5.31e-06	4.78e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	5.31e-06	4.78e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—TGFB1—multiple sclerosis	5.3e-06	4.77e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—MAPK1—multiple sclerosis	5.2e-06	4.68e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	5.08e-06	4.57e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—IL6—multiple sclerosis	4.81e-06	4.33e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	4.72e-06	4.25e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	4.72e-06	4.25e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	4.71e-06	4.24e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	4.62e-06	4.15e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	4.39e-06	3.95e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	4.37e-06	3.94e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IL6—multiple sclerosis	4.34e-06	3.91e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	4.29e-06	3.86e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IL6—multiple sclerosis	4.19e-06	3.77e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IL6—multiple sclerosis	3.99e-06	3.59e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	3.55e-06	3.19e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	3.3e-06	2.97e-05	CbGpPWpGaD
